An investigation for investors in Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares over potential securities laws violations by Fulcrum Therapeutics, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 10/18/2019 -- An investigation was announced over possible securities laws violations by Fulcrum Therapeutics, Inc. in connection with certain financial statements.
Investors who purchased shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Fulcrum Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Cambridge, MA based Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. On July 17, 2019, Fulcrum Therapeutics, Inc announced the pricing of its initial public offering ("IPO") of 4.5 million shares at $16.00 per share, for gross proceeds of $72.0 million.
However, since the IPO shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) declined to $6.27 per share on October 3, 2019.
Those who purchased shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels